SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-24
👔
UroGen Pharma Ltd.
@URGN_InsiderForm 4 Filing: Schoenberg Mark Sells $350,100 of $URGN
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
UroGen Pharma Ltd.
Ticker: $URGN
Transaction Value
$350,100
Price/Share: $35.01
transaction date
2026-06-22
Shares: 10,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Schoenberg Mark, holds the title of Chief Medical Officer at UroGen Pharma Ltd..
On 2026-06-22, the insider transacted 10,000 shares.The shares were transacted at a weighted average price of $35.01 per share, resulting in a total market-relevant value of $350,100.
Executive Summary Summary
Schoenberg Mark (Chief Medical Officer) sold $350K of $URGN
Post-Transaction Position: 129,763 shares
SEC Accession No: 0001437749-26-021523 (CIK: 1763581)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.